Market Growth Is Driven by Technological Innovations and An Increasing Incidence of Chronic Diseases.Pune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Global Positron Emission Tomography Market Size & Growth ...

Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered ...

GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging (MPI) agent, Flyrcado (flurpiridaz F 18) injection, to detect coronary artery ...

Expanding medical services to the area so people can stay closer to home continues to be the focus of the WVU Medicine Camden ...

GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...

Several ASX-listed healthcare companies with low market caps are making strides in tackling cancer,  a leading cause of death ...

Researchers from Astrazeneca plc and Karolinska Institutet have described the positron emission tomography (PET) evaluation of [11C]AZD-2423, a chemokine receptor type 2 (CCR2) radioligand in ...

Early detection of Alzheimer’s disease (AD) can improve treatment outcomes, but current testing methods still have ...

Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 ...